BCDA BioCardia, Inc.

Fundamentals / CIK 0000925741 / USD

BioCardia, Inc. reported $0 in revenue and a net loss of $7.67M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BCDA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$2.92M$1.46M$0-$14.14MFY 2016 Revenue: $576KFY 2016 Net Income: -$10.31M2016FY 2017 Revenue: $479KFY 2017 Net Income: -$12.31M2017FY 2018 Revenue: $625KFY 2018 Net Income: -$13.99M2018FY 2019 Revenue: $710KFY 2019 Net Income: -$14.71M2019FY 2020 Revenue: $145KFY 2020 Net Income: -$15.00M2020FY 2021 Revenue: $1.01MFY 2021 Net Income: -$12.62M2021FY 2022 Revenue: $1.35MFY 2022 Net Income: -$11.91M2022FY 2023 Revenue: $477KFY 2023 Net Income: -$11.57M2023FY 2024 Revenue: $58KFY 2024 Net Income: -$7.95M2024FY 2025 Revenue: $0FY 2025 Net Income: -$8.23M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $58K $477K $1.35M $1.01M $145K $710K $625K $479K $576K
Cost of Revenue -- -- -- -- $0 $4.0K $358K $517K $690K $746K
Gross Profit -- -- -- -- $1.01M $141K $352K $108K -$211K -$170K
Research & Development $4.96M $4.39M $7.73M $8.83M $8.56M $9.81M $8.56M $8.45M $5.80M $3.33M
Selling, General & Admin $3.32M $3.67M $4.39M $4.42M $5.09M $5.86M $6.00M $5.76M $6.39M $4.11M
Operating Income -$8.28M -$8.00M -$11.64M -$11.90M -$12.63M -$15.53M -$14.21M -$14.10M -$12.40M -$7.61M
EBITDA -$8.25M -$7.93M -$11.56M -$11.82M -$12.57M -$15.46M -$14.10M -$14.01M -$12.33M -$7.57M
Interest Income -- -- -- -- $9.0K $21K -- -- -- --
Interest Expense -- -- -- -- $0 $3.0K $112K -- $0 $1.74M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$8.23M -$7.95M -$11.57M -$11.91M -$12.62M -$15.00M -$14.71M -$13.99M -$12.31M -$10.31M
Basic EPS -$1.23 -$2.90 -$8.19 -$10.05 -$11.25 -$22.20 -$39.15 -$49.20 -$43.50 -$18.45
Diluted EPS -- -- -- -- -$11.25 -$22.20 -$39.15 -$49.20 -$43.50 -$18.45
Basic Shares Outstanding 6.7M 2.7M 1.4M 1.2M 1.1M 674.6K 376.3K 284.3K 282.7K 557.9K
Diluted Shares Outstanding -- -- -- -- 1.1M 674.6K 376.3K 284.3K 282.7K 557.9K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- $0 $0 $0 $0 $0
Research & Development $1.24M $893K $1.24M $1.13M $936K $1.37M $1.53M $1.42M
Selling, General & Admin $600K $730K $1.03M $885K $552K $683K $1.20M $906K
Operating Income -$1.83M -$1.62M -$2.27M -$2.01M -$1.49M -$2.05M -$2.73M -$2.32M
EBITDA -$1.83M -$1.62M -$2.26M -$2.01M -$1.48M -$2.05M -$2.71M -$2.31M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$1.82M -$1.61M -$2.26M -$1.98M -$1.48M -$2.05M -$2.71M -$2.30M
Basic EPS -$0.12 -$0.13 -$0.21 -- -$0.24 -$0.40 -$0.59 --
Diluted EPS -- -- -$0.21 -- -$0.24 -$0.40 -$0.59 --
Basic Shares Outstanding 15.1M 12.1M 10.8M -- 6.3M 5.1M 4.6M --
Diluted Shares Outstanding -- -- 10.8M -- 6.3M 5.1M 4.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $2.50M $2.37M $1.10M $7.36M $12.87M $21.41M $5.58M $5.36M $12.69M $21.35M
Cash & Short-Term Investments $2.50M $2.37M $1.10M $7.36M $12.87M $21.41M $5.58M $5.36M $12.69M $21.35M
Accounts Receivable, Net $20K $0 $63K $201K $147K $232K $147K $274K $95K $74K
Inventory -- -- -- -- -- -- $4.0K $141K $191K $135K
Total Current Assets $2.73M $2.62M $1.46M $7.86M $13.48M $22.66M $6.38M $6.22M $13.31M $21.92M
Property, Plant & Equipment, Net $16K $33K $94K $170K $182K $145K $181K $145K $169K $111K
Other Non-Current Assets $171K $171K $171K $171K $172K $54K $54K $54K $54K $54K
Total Non-Current Assets $681K $1.10M $1.53M $1.93M $2.24M $766K $1.30M $199K $223K $165K
Total Assets $3.41M $3.72M $2.99M $9.79M $15.72M $23.42M $7.68M $6.42M $13.54M $22.08M
Accounts Payable $641K $385K $890K $683K $507K $746K $914K $743K $902K $525K
Deferred Revenue (Current) -- -- $0 $341K $847K $683K $102K $112K $61K $71K
Total Current Liabilities $2.43M $2.32M $3.61M $3.58M $3.71M $4.25M $4.00M $2.55M $2.33M $1.44M
Deferred Revenue (Non-Current) -- -- -- -- -- -- $691K -- -- --
Total Non-Current Liabilities $86K $566K $982K $1.32M $1.63M $0 $1.30M $77K $81K $56K
Total Liabilities $2.52M $2.89M $4.59M $4.90M $5.34M $4.25M $5.31M $2.62M $2.41M $1.50M
Total Debt (incl. Leases) $528K $951K $1.31M $1.63M $1.87M $614K $1.14M -- -- --
Common Stock $11K $5.0K $2.0K $20K $17K $16K $7.0K $5.0K $38K $38K
Retained Earnings -$168.3M -$160.1M -$152.2M -$140.6M -$128.7M -$116.1M -$101.1M -$86.36M -$72.45M -$60.14M
Total Stockholders' Equity $895K $837K -$1.60M $4.89M $10.38M $19.18M $2.37M $3.79M $11.12M $20.58M
Total Equity $895K $837K -$1.60M $4.89M $10.38M $19.18M $2.37M $3.79M $11.12M $20.58M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $2.22M $4.12M $951K $2.50M $5.29M $980K $949K $2.37M
Cash & Short-Term Investments $2.22M $4.12M $951K $2.50M $5.29M $980K $949K $2.37M
Accounts Receivable, Net $30K $30K $20K $20K -- $10K -- $0
Total Current Assets $2.33M $4.30M $1.14M $2.73M $5.37M $1.20M $1.17M $2.62M
Property, Plant & Equipment, Net $12K $13K $16K $16K $13K $17K $16K $33K
Other Non-Current Assets $171K $171K $171K $171K $171K $171K $171K $171K
Total Non-Current Assets $739K $457K $572K $681K $783K $890K $993K $1.10M
Total Assets $3.07M $4.75M $1.71M $3.41M $6.15M $2.09M $2.17M $3.72M
Accounts Payable $418K $541K $820K $641K $1.08M $1.23M $818K $385K
Total Current Liabilities $2.09M $2.06M $2.78M $2.43M $3.31M $3.64M $3.23M $2.32M
Total Non-Current Liabilities $144K $0 $0 $86K $211K $333K $452K $566K
Total Liabilities $2.24M $2.06M $2.78M $2.52M $3.52M $3.98M $3.69M $2.89M
Total Debt (incl. Leases) $565K $293K $412K $528K $638K $745K $850K $951K
Common Stock $15K $15K $11K $11K $11K $6.0K $5.0K $5.0K
Retained Earnings -$174.0M -$172.2M -$170.6M -$168.3M -$166.4M -$164.9M -$162.8M -$160.1M
Total Stockholders' Equity $835K $2.70M -$1.07M $895K $2.63M -$1.89M -$1.52M $837K
Total Equity $835K $2.70M -$1.07M $895K $2.63M -$1.89M -$1.52M $837K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$8.23M -$7.95M -$11.57M -$11.91M -$12.62M -$15.00M -$14.71M -$13.99M -$12.31M -$10.31M
Depreciation & Amortization $24K $67K $84K $82K $60K $68K $111K $88K $78K $39K
Stock-Based Compensation $430K $741K $1.03M $1.18M $1.66M $2.95M $2.72M $2.77M $2.71M $942K
Change in Receivables -$20K $97K $115K -$54K $85K -$85K $127K -$179K -$21K $33K
Change in Inventory -- -- -- -- $0 $4.0K $137K $49K -$56K $27K
Change in Payables $163K -$316K $184K $4.0K -$239K -$168K $171K $119K $377K -$17K
Operating Cash Flow -$7.44M -$7.89M -$9.97M -$10.56M -$10.37M -$12.36M -$9.45M -$11.07M -$8.67M -$5.52M
Capital Expenditure -$7.0K -$6.0K -$12K -$70K -$116K -$32K -$146K -$66K -$136K --
Free Cash Flow -$7.44M -$7.89M -$9.99M -$10.63M -$10.48M -$12.39M -$9.59M -$11.13M -$8.81M --
Investing Cash Flow -$7.0K -$6.0K -$12K -$70K -$116K -$32K -$146K -$66K -$136K $18.92M
Common Stock Issued $8.69M $10.55M $4.39M $5.54M $2.00M $0 -- -- -- --
Financing Cash Flow $7.57M $9.16M $3.73M $5.12M $1.95M $28.21M $9.82M $3.80M $144K $4.40M
Net Change in Cash $125K $1.27M -$6.26M -$5.51M -$8.54M $15.82M $227K -- -- --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.82M -$1.61M -$2.26M -$1.98M -$1.48M -$2.05M -$2.71M -$2.30M
Depreciation & Amortization $2.0K $3.0K $3.0K $3.0K $4.0K $5.0K $12K $15K
Stock-Based Compensation $117K $109K $113K $85K $77K $98K $170K $176K
Change in Receivables -- -- -- -$20K $10K -$10K $0 $10K
Change in Payables -$116K -$255K $247K -$365K -$213K $319K $422K -$151K
Operating Cash Flow -$1.72M -$1.74M -$1.66M -$2.50M -$1.67M -$1.65M -$1.62M -$2.43M
Capital Expenditure -$1.0K $0 -$3.0K -$6.0K $0 -$1.0K $0 -$1.0K
Free Cash Flow -$1.72M -$1.74M -$1.66M -$2.50M -$1.67M -$1.65M -$1.62M -$2.43M
Investing Cash Flow -$1.0K $0 -$3.0K -$6.0K $0 -$1.0K $0 -$1.0K
Common Stock Issued $0 $5.08M $225K $0 $6.78M $1.70M $212K $39K
Financing Cash Flow -$172K $4.90M $117K -$288K $5.98M $1.68M $196K -$125K
Net Change in Cash -$1.89M $3.17M -$1.54M -$2.79M $4.31M $31K -$1.42M -$2.56M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- 100.0% 97.2% 49.6% 17.3% -44.1% -29.5%
Operating Margin -- -13794.8% -2441.1% -880.3% -1244.3% -10709.7% -2001.8% -2256.3% -2589.8% -1320.8%
Net Profit Margin -- -13700.0% -2425.8% -880.7% -1243.6% -10347.6% -2071.7% -2237.9% -2569.5% -1789.9%
Return on Equity (ROE) -919.3% -949.3% -- -243.4% -121.7% -78.2% -620.6% -368.9% -110.6% -50.1%
Return on Assets (ROA) -241.1% -213.4% -387.4% -121.6% -80.3% -64.1% -191.6% -218.0% -90.9% -46.7%
Current Ratio 1.12x 1.13x 0.40x 2.19x 3.63x 5.33x 1.59x 2.44x 5.71x 15.18x
Quick Ratio 1.03x 1.02x 0.32x 2.11x 3.51x 5.09x 1.59x 2.39x 5.63x 15.08x
Debt to Equity 0.59x 1.14x -- 0.33x 0.18x 0.03x 0.48x -- -- --
Revenue Growth (YoY) -100.0% -87.8% -64.7% +33.2% +600.0% -79.6% +13.6% +30.5% -16.8% -36.3%
Gross Profit Growth (YoY) -- -- -- -- +619.9% -59.9% +225.9% -- -- --
5Y Revenue / Share Growth -100.0% -98.9% -84.6% -32.5% -12.8% -97.5% -- -- -- --
10Y Revenue / Share Growth -100.0% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -- -- -- -281733.3% -13794.8%
Net Profit Margin -- -- -- -- -- -- -279700.0% -13700.0%
Return on Equity (ROE) -918.9% -271.8% -- -919.3% -325.1% -- -- -949.3%
Return on Assets (ROA) -249.9% -154.3% -454.1% -241.1% -138.9% -421.0% -387.4% -213.4%
Current Ratio 1.11x 2.09x 0.41x 1.12x 1.62x 0.33x 0.36x 1.13x
Quick Ratio 1.08x 2.02x 0.35x 1.03x 1.60x 0.27x 0.29x 1.02x
Debt to Equity 0.68x 0.11x -- 0.59x 0.24x -- -- 1.14x
Revenue Growth (YoY) -- -- -- -- -- -100.0% -100.0% -100.0%
Source: SEC EDGAR CompanyFacts (CIK 0000925741) · from June 30, 2010 Data through September 30, 2026 · synced Nov 21, 2026, 05:05 UTC · Open in terminal